ReviewFolia microbiologica2026
Advances on Sporisorium reilianum: microbiology along with chemistry, bioactivity, and application.
Review in Folia microbiologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Sporisorium reilianum (S. reilianum) is a phytopathogenic fungus that infects Poaceae plants such as sorghum and maize. The sclerotium formed on sorghum, known as "Sphacelotheca sorghi(Link) Clint(S. sorghi)", is a traditional resource with both medicinal and edible applications, valued for its purported effects in regulating menstruation, stopping bleeding, and protecting the liver. Although research on this fungus has increased significantly in recent years, a comprehensive academic review remains lacking. The limited number of existing reviews primarily focus on the perspective of plant pathology, missing an interdisciplinary integration encompassing microbiology, chemistry, and bioactivity. Therefore, this study provides a cross-disciplinary systematic review. At the microbiological level, it elaborates on six key areas: host specialization and adaptation, life cycle and infection process, pathogenic symptoms, effector proteins and molecular mechanisms, host defense, and genomic evolution. Chemically, it summarizes the major identified active components, including polysaccharides, steroids, alkaloids, melanin, and benzoic acid derivatives, amounting to a total of nine compounds. Regarding bioactivity, it reviews experimental evidence for its antioxidant, antitumor, anti-inflammatory, and anti-enteritis effects, alongside potential applications in areas such as anti-obesity and the development of functional foods and health products. This work aims to provide a foundational reference and forward-looking perspective to facilitate further research, resource development, and comprehensive utilization of this fungus.
Indexed as
Identifiers
41979814What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.